What is the corporate vision of Arnold Pharmaceuticals?

Arno Pharmaceuticals’ corporate vision is to “become a world-class biopharmaceutical company that benefits patients around the world.” As a clinical-stage global biopharmaceutical company, Arnold Medicine adheres to the mission of “turning cancer into a chronic disease or even a cure” and is committed to becoming an innovative R&D enterprise that creates “new global” oncology drugs, with better quality products. The treatment benefits patients in China and even around the world. In 2016, Arnold Pharmaceutical was restructured and established in Hangzhou, China, with R&D and clinical operation centers in both China and the United States. At present, Arnold Pharmaceuticals has assembled a world-class leadership and R&D team, a unique drug development technology platform, and cooperates with a number of global pharmaceutical companies. Through the "joint innovation" and "independent research and development" models, it has created multiple global product pipelines, currently covering more than 10 anti-tumor drug candidates.